Research ArticlePerspective
Contribution of Metabolites to P450 Inhibition-Based Drug-Drug Interactions: Scholarship from the IQ DMLG Metabolite Group
Hongbin Yu, Suresh K. Balani, Weichao Chen, Donghui Cui, Ling He, William Griffith Humphreys, Jialin Mao, W. George Lai, Anthony J. Lee, Heng-Keang Lim, Christopher MacLauchlin, Chandra Prakash, Sekhar Surapaneni, Susanna Tse, Alana Upthagrove, Robert L. Walsky, Bo Wen and Zhaopie Zeng
Drug Metabolism and Disposition February 5, 2015, dmd.114.059345; DOI: https://doi.org/10.1124/dmd.114.059345
Hongbin Yu
1 Boehringer Ingelheim Pharmaceuticals. Inc.;
Suresh K. Balani
2 Takeda Pharmaceuticals International Co.;
Weichao Chen
3 Vertex Pharmaceuticals;
Donghui Cui
4 Merck Research Laboratories;
Ling He
5 Daiichi Sankyo, Inc.;
William Griffith Humphreys
6 Bristol-Myers-Squibb;
Jialin Mao
7 Genentech;
W. George Lai
8 Eisai Pharmaceuticals;
Anthony J. Lee
9 Abbivie;
Heng-Keang Lim
10 Janssen Research and Development;
Christopher MacLauchlin
11 GlaxoSmithKline;
Chandra Prakash
12 Biogen Idec;
Sekhar Surapaneni
13 Celgene Corporation;
Susanna Tse
14 Pfizer Inc.;
Alana Upthagrove
15 Novartis Pharmaceuticals Corporation;
Robert L. Walsky
16 EMD Serono Research Institute;
Bo Wen
11 GlaxoSmithKline;
Data Supplement
Files in this Data Supplement:
- Supplemental Table -
Supplemental Table